CSIMarket
 


Haemonetics Corporation  (HAE)
Other Ticker:  
 

Haemonetics's Long Term Debt to Equity

HAE's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth


Due to net new long-term borrowings of 14.45%, Long Term Debt to Equity fell to 0.91, above the Haemonetics's average Long Term Debt to Equity.

Within Medical Equipment & Supplies industry in the third quarter 2023, 27 other companies have achieved lower Long Term Debt to Equity than Haemonetics in the III Quarter 2023. While Long Term Debt to Equity total ranking has improved so far in the third quarter 2023 to 749, from total ranking in the second quarter 2023 at 1769 .

Explain Long Term Debt to Equity Ratio?
How much Long Term Debt HAE´s has?
What is the structure of HAE´s Equity?


HAE Long Term Debt to Equity (Dec 30 2023)
III. Quarter
(Sep 30 2023)
II. Quarter
(Jul 01 2023)
I. Quarter
(Apr 01 2023)
IV. Quarter
(Dec 31 2022)
III. Quarter
Y / Y Equity Change 21.57 % 22.59 % 12.23 % 9.15 % 6.19 %
Y / Y Long Term Debt Change 13.22 % -1.43 % -1.54 % 34.8 % 19.54 %
Long Term Debt to Equity MRQ 0.91 0.84 0.87 0.92 0.98
HAE's Total Ranking # 749 # 1769 # 2213 # 1759 # 1987
Seq. Equity Change 5.56 % 3.36 % 5.7 % 5.41 % 6.44 %
Seq. Long Term Debt Change 14.45 % -0.36 % -0.36 % -0.36 % -0.36 %



Long Term Debt to Equity third quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 28
Healthcare Sector # 64
Overall Market # 749


Long Term Debt to Equity Statistics
High Average Low
1.13 0.55 0
(Jul 03 2021)   (Jun 30 2012)




Financial Statements
Haemonetics's Equity $ 943 Millions Visit HAE's Balance sheet
Haemonetics's Long Term Debt $ 857 Millions Visit HAE's Balance sheet
Source of HAE's Sales Visit HAE's Sales by Geography


Cumulative Haemonetics's Long Term Debt to Equity

HAE's Long Term Debt to Equity for the trailling 12 Months

HAE Long Term Debt to Equity

(Dec 30 2023)
III. Quarter
(Sep 30 2023)
II. Quarter
(Jul 01 2023)
I. Quarter
(Apr 01 2023)
IV. Quarter
(Dec 31 2022)
III. Quarter
Y / Y Equity TTM Growth 21.57 % 22.59 % 12.23 % 9.15 % 6.19 %
Y / Y Long Term Debt TTM Growth 13.22 % -1.43 % -1.54 % 34.8 % 19.54 %
Long Term Debt to Equity TTM 0.88 0.9 0.95 0.98 0.94
Total Ranking TTM # 47 # 21 # 58 # 122 # 118
Seq. Equity TTM Growth 5.56 % 3.36 % 5.7 % 5.41 % 6.44 %
Seq. Long Term Debt TTM Growth 14.45 % -0.36 % -0.36 % -0.36 % -0.36 %


On the trailing twelve months basis Despite of the net new long-term borrowings of 14.45% during the twelve months period ending in III Quarter 2023 Haemonetics has managed to decrease Long Term Debt to Equity in the III Quarter 2023 to 0.88, above the HAE's average Long Term Debt to Equity.
Long Term Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Medical Equipment & Supplies industry 2, during the past 12 months, other companies have achieved lower Long Term Debt to Equity than Haemonetics. While Long Term Debt to Equity total ranking has deteriorated during the twelve months ending in the III Quarter 2023, compared to the prior period, from 21 to 47.

Explain Long Term Debt to Equity Ratio?
How much Long Term Debt HAE´s has?
What is the structure of HAE´s Equity?

TTM Long Term Debt to Equity Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 3
Healthcare Sector # 9
Within the Market # 47


trailing twelve months Long Term Debt to Equity Statistics
High Average Low
0.98 0.64 0.19
(Jan 01 2022)   (Mar 31 2018)




Companies with similar Long Term Debt to Equity in the quarter ending Dec 30 2023, within Medical Equipment & Supplies Industry Long Term Debt to EquityDec 30 2023 MRQ Long Term DebtDec 30 2023 MRQ Equity
Tela Bio Inc   2.15 $ 40.515  Millions$ 18.881  Millions
Owens and Minor inc  2.05 $ 1,890.598  Millions$ 924.166  Millions
Insulet Corporation  1.86 $ 1,366.400  Millions$ 732.700  Millions
Neuronetics inc   1.73 $ 59.283  Millions$ 34.190  Millions
Bioventus Inc   1.66 $ 366.998  Millions$ 221.118  Millions
Novocure Limited  1.57 $ 568.822  Millions$ 362.496  Millions
Baxter International Inc   1.31 $ 11,130.000  Millions$ 8,468.000  Millions
Zynex inc   1.25 $ 57.605  Millions$ 46.129  Millions
Apyx Medical Corporation  1.23 $ 33.185  Millions$ 26.922  Millions
Dexcom Inc   1.18 $ 2,434.200  Millions$ 2,068.600  Millions
Conmed Corporation  1.17 $ 973.140  Millions$ 834.222  Millions
Shockwave Medical Inc   1.09 $ 731.863  Millions$ 668.677  Millions
Artivion Inc   1.08 $ 305.531  Millions$ 281.780  Millions
Tandem Diabetes Care Inc   0.91 $ 285.035  Millions$ 313.632  Millions
Haemonetics Corporation  0.91 $ 856.849  Millions$ 943.319  Millions
Integra Lifesciences Holdings Corp  0.88 $ 1,395.818  Millions$ 1,587.884  Millions
Medinotec Inc   0.76 $ 1.581  Millions$ 2.075  Millions
Icu Medical Inc  0.74 $ 1,577.770  Millions$ 2,123.410  Millions
Merit Medical Systems Inc  0.68 $ 823.013  Millions$ 1,202.000  Millions
Bausch and Lomb Corp  0.65 $ 4,532.000  Millions$ 6,920.000  Millions
Cadre Holdings Inc   0.65 $ 127.812  Millions$ 197.162  Millions
Masimo Corp  0.64 $ 871.700  Millions$ 1,364.800  Millions
Integer Holdings Corporation  0.63 $ 959.925  Millions$ 1,519.042  Millions
Beyond Air Inc   0.61 $ 14.380  Millions$ 23.471  Millions
Glaukos Corp  0.61 $ 282.773  Millions$ 461.766  Millions
Msa Safety Incorporated  0.59 $ 575.170  Millions$ 966.802  Millions
National Vision Holdings Inc   0.54 $ 450.771  Millions$ 829.418  Millions
Steris Plc  0.50 $ 3,231.075  Millions$ 6,428.099  Millions
Silk Road Medical Inc   0.50 $ 75.626  Millions$ 151.151  Millions
Clearpoint Neuro Inc   0.47 $ 9.949  Millions$ 21.173  Millions

Date modified: 2024-02-08T15:54:54+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com